<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
LEGN
Legend Biotech
$
()


  • Legend's CARVYKTI approved by FDA for second-line treatment of multiple myeloma

    4/7/2024 - 06:25am
  • Cantor starts Legend Biotech at Overweight on Carvykti expansion

    4/3/2024 - 06:49am
  • Legend Biotech initiated with bullish view at Cantor Fitzgerald

    4/3/2024 - 06:12am
  • Legend Biotech files automatic mixed securities shelf

    3/19/2024 - 07:59am
  • Legend Biotech price target raised by $5 at UBS, here's why

    3/17/2024 - 06:25am
  • Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma

    3/15/2024 - 15:17pm
  • Legend Biotech initiated with bullish view at Raymond James, here's why

    3/13/2024 - 08:44am
  • Legend Biotech initiated with bullish view at Raymond James

    3/12/2024 - 16:15pm
  • What You Missed On Wall Street On Monday

    3/11/2024 - 16:22pm
  • What You Missed On Wall Street This Morning

    3/11/2024 - 12:01pm
  • Legend Biotech reports Q4 EPS (40c), consensus (83c)

    3/11/2024 - 07:04am
  • Legend Biotech gets CHMP recommendation for expansion of Carvykti label

    2/23/2024 - 07:23am
  • Legend Biotech price target raised by $1 at Barclays, here's why

    1/24/2024 - 05:52am
  • Legend Biotech initiated with neutral view at Scotiabank, here's why

    12/19/2023 - 07:41am
  • Legend Biotech reports outcomes in CARTITUDE-4 study of CARVYKTI

    12/11/2023 - 19:46pm
dynamic_feed Breaking News